DTP hepatitis B vaccine/Hib-meningococcal vaccine - GlaxoSmithKline

Drug Profile

DTP hepatitis B vaccine/Hib-meningococcal vaccine - GlaxoSmithKline

Alternative Names: Globorix; Tritanrix™-HepB/Hib-MenAC vaccine

Latest Information Update: 14 Nov 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GlaxoSmithKline
  • Class Haemophilus vaccines; Hepatitis B vaccines; Meningococcal vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Diphtheria; Haemophilus infections; Hepatitis B; Meningococcal group A infections; Meningococcal group C infections; Pertussis; Tetanus

Most Recent Events

  • 16 Oct 2007 Discontinued - Preregistration for Diphtheria in European Union (Parenteral)
  • 16 Oct 2007 Discontinued - Preregistration for Haemophilus infections in European Union (Parenteral)
  • 16 Oct 2007 Discontinued - Preregistration for Hepatitis B in European Union (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top